Acne News and Research RSS Feed - Acne News and Research

Acne is a disorder resulting from the action of hormones and other substances on the skin's oil glands (sebaceous glands) and hair follicles. These factors lead to plugged pores and outbreaks of lesions commonly called pimples or zits. Acne lesions usually occur on the face, neck, back, chest, and shoulders. Although acne is usually not a serious health threat, it can be a source of significant emotional distress. Severe acne can lead to permanent scarring.
Acne: when to seek help?

Acne: when to seek help?

Acne develops due to an interplay between genetic factors (so people often have a family history) and hormonal factors that can increase the size and activity of the sebaceous or oil gland. [More]
Mesoporous material can inhibit growth of bacteria linked to acne and hospital acquired infections

Mesoporous material can inhibit growth of bacteria linked to acne and hospital acquired infections

The mesoporous material Upsalite is shown to inhibit growth of bacteria associated with acne and hospital acquired infections. [More]
Phage therapy may be solution to treating antibiotic-resistant bacterial infections

Phage therapy may be solution to treating antibiotic-resistant bacterial infections

Phage therapy may be a solution to treating infections caused by antibiotic-resistant bacteria. Since 2013, researchers at the University of Helsinki in Finland have collected bacteriophages to combat antibiotic-resistant bacterial strains, and hope to start clinical phage therapy trials in the near future. [More]
Common bacteria on human skin may offer protection against diseases

Common bacteria on human skin may offer protection against diseases

There are more and more examples of the ways in which we can benefit from our bacteria. According to researcher Rolf Lood from Lund University in Sweden, this is true for the skin as well. [More]
Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan plc, a leading global pharmaceutical company, today announced the availability of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy [More]
Dermatologists offer tips to help men develop healthy skin care routines

Dermatologists offer tips to help men develop healthy skin care routines

When it comes to skin care, men have traditionally kept it simple. However, experts say more men are now pursuing healthier, younger-looking skin. [More]
Men can take contraceptives to prevent pregnancy in female partners, study shows

Men can take contraceptives to prevent pregnancy in female partners, study shows

Men can take birth control shots to prevent pregnancy in their female partners, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. [More]
Natural compound found in red wine can lower testosterone levels in women with PCOS

Natural compound found in red wine can lower testosterone levels in women with PCOS

Resveratrol—a natural compound found in red wine and grapes—can help address a hormone imbalance in women with polycystic ovary syndrome (PCOS), a leading cause of infertility in women, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. [More]
SWAT team of immune cells linked to low infection rates after cleft lip and palate surgery in infants

SWAT team of immune cells linked to low infection rates after cleft lip and palate surgery in infants

The mouth is widely considered the dirtiest part of the human body, yet babies have surprisingly low infection rates following cleft lip and palate surgery. [More]
British Skin Foundation celebrates 20 years of research

British Skin Foundation celebrates 20 years of research

Sixty percent of British people currently suffer from or have suffered from a skin disease at some point during their lifetime according to a new survey revealed at the British Skin Foundation’s Skin Deep – 20 Years of Research conference on 13th October in London. [More]
Soy isoflavones may help improve metabolic and cardiovascular health in women with PCOS

Soy isoflavones may help improve metabolic and cardiovascular health in women with PCOS

Women who have polycystic ovary syndrome (PCOS)—a common cause of female infertility—may be able to improve their metabolic and cardiovascular health by consuming soy isoflavones, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. [More]
Scarring can have negative impact on patients' quality of life

Scarring can have negative impact on patients' quality of life

Whether it's from sudden trauma, scheduled surgery or serious acne, scarring can have a profound impact on patients. [More]
Deadly bacteria can travel to the brain and spinal cord in 24 hours, new study finds

Deadly bacteria can travel to the brain and spinal cord in 24 hours, new study finds

A deadly bacteria that can be picked up by a simple sniff can travel to the brain and spinal cord in just 24 hours, a new Griffith University and Bond University study has found. [More]
FDA approves new topical retinoid gel for OTC treatment of acne

FDA approves new topical retinoid gel for OTC treatment of acne

The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older. [More]
Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses. [More]
TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

Merck, a leading science and technology company, will present data at the ESMO 18th World Congress on Gastrointestinal Cancer from the pivotal Phase III TAILOR study in patients from China, the first prospective trial to evaluate an anti-EGFR antibody in the first-line therapy of patients with RAS wild-type metastatic colorectal cancer (mCRC). [More]
Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug Administration to market ACZONE (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older. [More]
First patient dosed in Novan's Phase 3 program to evaluate efficacy of SB204 Gel in treatment of acne

First patient dosed in Novan's Phase 3 program to evaluate efficacy of SB204 Gel in treatment of acne

Novan, Inc. today announced that the first patient has been dosed in its Phase 3 program to evaluate the efficacy and safety of its topical nitric oxide product candidate SB204 Gel in the treatment of acne vulgaris ("acne"). The Company is running two identically designed Phase 3 pivotal trials in parallel and expects to report top-line results in the first half of 2017. [More]
Early strength training could help prevent ACL injuries in young women

Early strength training could help prevent ACL injuries in young women

Young women demonstrate less strength and neuromuscular control after puberty, and this may make them particularly susceptible to Anterior Cruciate Ligament (ACL) injuries, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif. [More]

Perrigo closes previously announced acquisition of generic Retin-A portfolio from Matawan Pharmaceuticals

Perrigo Company plc announced today that it has completed the previously announced acquisition of a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals, LLC. [More]
Advertisement
Advertisement